{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:24:12Z","timestamp":1787027052895,"version":"build-2736575974"},"reference-count":185,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Mpox, caused by the monkeypox virus (MPXV), is a zoonotic disease that has gained global relevance after the 2022\u20132024 outbreak. MPXV exists in two distinct clades: clade I, associated with higher virulence and mortality, and clade II, which demonstrated increased human-to-human transmission and adaptation. Clinically, Mpox presents with rash, fever, and lymphadenopathy, with severe complications in immunocompromised individuals. Genomic surveillance has revealed rapid evolution, partly driven by APOBEC3-mediated mutagenesis, especially within immune-modulating regions. Although smallpox vaccines like MVA-BN and ACAM2000 provide cross-protection against Mpox, the MVA-BN vaccine showed a more favourable safety profile, but variable effectiveness compared to replicating vaccines. Antiviral agents such as tecovirimat and cidofovir have been used off-label, but emerging resistance and limited clinical efficacy highlight an urgent need for MPXV-specific therapeutics. The current epidemiological scenario emphasizes the importance of novel antiviral development and optimized prophylactic strategies to improve clinical outcomes and global preparedness. This review aims to provide a comprehensive overview of the molecular biology, clinical features, the current drugs used to treat Mpox infection and the vaccines used to prevent the infection. It also discussing the limitations of these therapeutic tools and the improvements needed to enhance their efficacy.<\/jats:p>","DOI":"10.3389\/fphar.2025.1665830","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T05:42:29Z","timestamp":1758692549000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Genomic variability and immunological aspects involved in response to MPXV infection"],"prefix":"10.3389","volume":"16","author":[{"given":"Simone","family":"La Frazia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rosa","family":"Garbuglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pauciullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verdiana","family":"Zulian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Del Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"101003","DOI":"10.1016\/j.onehlt.2025.101003","article-title":"Mpox alert: COVID-19\u2019s hard-earned lessons put to the test","volume":"20","author":"Adebiyi","year":"2025","journal-title":"One Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3390\/v14061283","article-title":"Travel-related monkeypox outbreaks in the era of COVID-19 pandemic: are we prepared?","volume":"14","author":"Adegboye","year":"2022","journal-title":"Viruses"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1360586","DOI":"10.3389\/fcimb.2024.1360586","article-title":"A comprehensive review of monkeypox virus and mpox characteristics","volume":"14","author":"Alakunle","year":"2024","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e2220415120","DOI":"10.1073\/pnas.2220415120","article-title":"Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model","volume":"120","author":"Americo","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1097\/01.inf.0000101821.61387.a5","article-title":"A case of severe monkeypox virus disease in an American child: emerging infections and changing professional values","volume":"22","author":"Anderson","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"9391","DOI":"10.1128\/JVI.00605-06","article-title":"Cidofovir resistance in vaccinia virus is linked to diminished virulence in mice","volume":"80","author":"Andrei","year":"2006","journal-title":"J. Virol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"taz002","DOI":"10.1093\/jtm\/taz002","article-title":"Monkeypox transmission among international travellers-serious monkey business?","volume":"26","author":"Angelo","year":"2019","journal-title":"J. Travel Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2200421","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200421","article-title":"Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022","volume":"27","author":"Antinori","year":"2022","journal-title":"Euro Surveill."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e70180","DOI":"10.1002\/jmv.70180","article-title":"MPXV: update on morphological and morphogenesis aspects through transmission and scanning electron microscopies and 3D reconstruction","volume":"97","author":"Barreto-Vieira","year":"2025","journal-title":"J. Med. Virol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1038\/s41467-024-48180-w","article-title":"Predicting vaccine effectiveness for mpox","volume":"15","author":"Berry","year":"2024","journal-title":"Nat. Commun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5910","DOI":"10.1128\/JVI.65.11.5910-5920.1991","article-title":"Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein","volume":"65","author":"Blasco","year":"1991","journal-title":"J. Virol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e27931","DOI":"10.1002\/jmv.27931","article-title":"Epidemiological trends and clinical features of the ongoing monkeypox epidemic: a preliminary pooled data analysis and literature review","volume":"95","author":"Bragazzi","year":"2023","journal-title":"J. Med. Virol."},{"key":"B13","first-page":"851","article-title":"Studies of host immunomodulation and prevention of pancreatic beta cell destruction","volume":"22","author":"Brayman","year":"1990","journal-title":"Transpl. Proc."},{"key":"B14","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s11262-023-02002-1","article-title":"Extensive ITR expansion of the 2022 Mpox virus genome through gene duplication and gene loss","volume":"59","author":"Brinkmann","year":"2023","journal-title":"Virus Genes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"114888","DOI":"10.1016\/j.jviromet.2024.114888","article-title":"Genome sequencing of the mpox virus 2022 outbreak with amplicon-based Oxford nanopore MinION sequencing","volume":"325","author":"Brinkmann","year":"2024","journal-title":"J. Virol. Methods"},{"key":"B16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/cid\/ciad584","article-title":"Single-dose effectiveness of mpox vaccine in Quebec, Canada: test-negative design with and without adjustment for self-reported exposure risk","volume":"78","author":"Brousseau","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/tropicalmed1010008","article-title":"Human monkeypox: current state of knowledge and implications for the future","volume":"1","author":"Brown","year":"2016","journal-title":"Trop. Med. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0010141","DOI":"10.1371\/journal.pntd.0010141","article-title":"The changing epidemiology of human monkeypox-A potential threat? A systematic review","volume":"16","author":"Bunge","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.jacc.2003.11.053","article-title":"Smallpox vaccination and myopericarditis: a clinical review","volume":"43","author":"Cassimatis","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"B20","first-page":"304","article-title":"Human monkeypox--Kasai oriental, Zaire, 1996-1997","volume":"46","year":"1997","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B21","unstructured":"Biosafety laboratory guidance for handling and processing mpox specimens"},{"key":"B22","unstructured":"Biosafety laboratory guidance for handling and processing mpox specimens - select agent regulations"},{"key":"B23","unstructured":"Select agents and toxins list"},{"key":"B24","unstructured":"Clinical treatment of mpox"},{"key":"B25","unstructured":"Interim clinical considerations for use of vaccine for mpox prevention in the United States"},{"key":"B26","doi-asserted-by":"publisher","first-page":"100397","DOI":"10.1016\/j.ijregi.2024.100397","article-title":"The 2023 - 2024 multi-source mpox outbreaks of clade I MPXV in Sub-Saharan Africa: alarm bell for Africa and the world","volume":"12","author":"Cevik","year":"2024","journal-title":"IJID Reg."},{"key":"B27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.virol.2005.05.030","article-title":"Virulence differences between monkeypox virus isolates from West Africa and the Congo basin","volume":"340","author":"Chen","year":"2005","journal-title":"Virology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1038\/s41467-025-59370-5","article-title":"T cell memory response to MPXV infection exhibits greater effector function and migratory potential compared to MVA-BN vaccination","volume":"16","author":"Chen","year":"2025","journal-title":"Nat. Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"110532","DOI":"10.1016\/j.virol.2025.110532","article-title":"Emerging variants of Mpox virus and tecovirimat resistance: genomic insights and implications for treatment strategies","volume":"608","author":"Chenchula","year":"2025","journal-title":"Virology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5176","DOI":"10.1038\/s41467-025-60539-1","article-title":"Assembly and breakage of head-to-head double hexamer reveals mpox virus E5-catalyzed DNA unwinding initiation","volume":"16","author":"Cheng","year":"2025","journal-title":"Nat. Commun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1177\/00031348231177931","article-title":"Anorectal manifestations of treatment-refractory monkeypox requiring surgical intervention","volume":"89","author":"Cherfan","year":"2023","journal-title":"Am. Surg."},{"key":"B32","first-page":"24","article-title":"Recombinant vaccinia virus expressing Japanese encephalitis virus protein E","author":"Cheshenko","year":"1997","journal-title":"Mol. Gen. Mikrobiol. Virusol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1126\/science.adw1657","article-title":"Mpox drug wins approval in Japan\u2014But it doesn\u2019t work","volume":"387","author":"Cohen","year":"2025","journal-title":"Science"},{"key":"B34","volume-title":"Note for guidance on the development of vaccinia virus based vaccines against smallpox","year":"2002"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.3201\/eid2912.230849","article-title":"Treatment of mpox with suspected tecovirimat resistance in immunocompromised patient, United States, 2022","volume":"29","author":"Contag","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"553","DOI":"10.15585\/mmwr.mm7220a3","article-title":"Estimated effectiveness of JYNNEOS vaccine in preventing Mpox: a multijurisdictional case-control study \u2014 united States, August 19, 2022\u2013March 31, 2023","volume":"72","author":"Dalton","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"D54","DOI":"10.1016\/j.vaccine.2011.04.014","article-title":"Status of human monkeypox: clinical disease, epidemiology and research","volume":"29","author":"Damon","year":"2011","journal-title":"Vaccine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0166-3542(02)00008-6","article-title":"Cidofovir in the treatment of poxvirus infections","volume":"55","author":"De Clercq","year":"2002","journal-title":"Antivir. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1056\/nejmoa2215201","article-title":"Vaccine effectiveness of JYNNEOS against mpox disease in the United States","volume":"388","author":"Deputy","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0319922","DOI":"10.1128\/spectrum.03199-22","article-title":"Unique tandem repeats in the inverted terminal repeat regions of monkeypox viruses","volume":"11","author":"Desingu","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"B41","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1099\/0022-1317-79-2-347","article-title":"Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells","volume":"79","author":"Drexler","year":"1998","journal-title":"J. Gen. Virol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1128\/AAC.01601-13","article-title":"KAY-2-41, a novel nucleoside analogue inhibitor of orthopoxviruses in vitro and in vivo","volume":"58","author":"Duraffour","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B43","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat. Med."},{"key":"B44","unstructured":"Brincidofovir\n          \n          \n          2025"},{"key":"B45","unstructured":"Rapid scientific advice on public health measures for mpox (2024-2025)\n          \n          \n          2025"},{"key":"B46","unstructured":"Scientific discussion\n          \n          \n          2025"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e0005809","DOI":"10.1371\/journal.pntd.0005809","article-title":"Characterization of monkeypox virus infection in African rope squirrels (Funisciurus sp.)","volume":"11","author":"Falendysz","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/v15040905","article-title":"Monkeypox virus in animals: current knowledge of viral transmission and pathogenesis in wild animal reservoirs and captive animal models","volume":"15","author":"Falendysz","year":"2023","journal-title":"Viruses"},{"key":"B49","volume-title":"Smallpox and its eradication, history of international public health","author":"Fenner","year":"1988"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.7326\/M22-2183","article-title":"Detection of monkeypox virus in anorectal swabs from asymptomatic men who have sex with men in a sexually transmitted infection screening program in Paris, France","volume":"175","author":"Ferr\u00e9","year":"2022","journal-title":"Ann. Intern Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/ije\/17.3.643","article-title":"The transmission potential of monkeypox virus in human populations","volume":"17","author":"Fine","year":"1988","journal-title":"Int. J. Epidemiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"101828","DOI":"10.1016\/j.genrep.2023.101828","article-title":"Mutations of the monkeypox virus responsible for the 2022 outbreak","volume":"33","author":"Fouad","year":"2023","journal-title":"Gene Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1038\/s41564-022-01269-8","article-title":"Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations","volume":"7","author":"Frenois-Veyrat","year":"2022","journal-title":"Nat. Microbiol."},{"key":"B54","unstructured":"Monkeypox virus: infectious substances pathogen safety data sheet\n          \n          \n          2023"},{"key":"B55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/rmv.483","article-title":"Mechanisms of action of ribavirin against distinct viruses","volume":"16","author":"Graci","year":"2006","journal-title":"Rev. Med. Virol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(25)00180-x","article-title":"Effect of JYNNEOS vaccination on mpox clinical progression: a case\u2013control study","author":"Granskog","year":"2025","journal-title":"Lancet Infect. Dis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"638","DOI":"10.2471\/BLT.19.242347","article-title":"Modelling human-to-human transmission of monkeypox","volume":"98","author":"Grant","year":"2020","journal-title":"Bull. World Health Organ"},{"key":"B58","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/ced\/llad103","article-title":"Monkeypox whitlow: a novel presentation","volume":"48","author":"Grau Echevarr\u00eda","year":"2023","journal-title":"Clin. Exp. Dermatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"460","DOI":"10.15585\/mmwr.mm7320a3","article-title":"Monkeypox virus infections after 2 preexposure doses of JYNNEOS vaccine \u2014 united States, May 2022\u2013May 2024","volume":"73","author":"Guagliardo","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B60","doi-asserted-by":"publisher","first-page":"101102","DOI":"10.1016\/j.nmni.2023.101102","article-title":"Emergence, phylogeography, and adaptive evolution of mpox virus","volume":"52","author":"Guan","year":"2023","journal-title":"New Microbes New Infect."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.3201\/eid2810.221126","article-title":"Early estimates of monkeypox incubation period, generation time, and reproduction number, Italy, May-June 2022","volume":"28","author":"Guzzetta","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nm1273","article-title":"Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox","volume":"11","author":"Hammarlund","year":"2005","journal-title":"Nat. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"14567","DOI":"10.1073\/pnas.0800589105","article-title":"Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation","volume":"105","author":"Hammarlund","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B64","doi-asserted-by":"publisher","first-page":"7805","DOI":"10.1128\/jvi.03481-12","article-title":"Assessment of the protective effect of imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaques","volume":"87","author":"Hatch","year":"2013","journal-title":"J. Virol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1473-3099(23)00492-9","article-title":"Mpox in people with past infection or a complete vaccination course: a global case series","volume":"24","author":"Hazra","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41421-024-00741-5","article-title":"Molecular architecture of monkeypox mature virus","volume":"10","author":"Hong","year":"2024","journal-title":"Cell Discov."},{"key":"B67","doi-asserted-by":"publisher","first-page":"6778","DOI":"10.1038\/s41467-024-51074-6","article-title":"Multi-omics characterization of the monkeypox virus infection","volume":"15","author":"Huang","year":"2024","journal-title":"Nat. Commun."},{"key":"B68","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.virol.2014.06.039","article-title":"A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27","author":"Hughes","year":"2014","journal-title":"Virology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1099\/vir.0.005108-0","article-title":"A prairie dog animal model of systemic orthopoxvirus disease using West African and Congo Basin strains of monkeypox virus","volume":"90","author":"Hutson","year":"2009","journal-title":"J. Gen. Virol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/s41591-022-01907-y","article-title":"Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus","volume":"28","author":"Isidro","year":"2022","journal-title":"Nat. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1128\/JVI.75.3.1205-1210.2001","article-title":"Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox","volume":"75","author":"Jackson","year":"2001","journal-title":"J. Virol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"eadl4317","DOI":"10.1126\/scitranslmed.adl4317","article-title":"Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques","volume":"16","author":"Jacob-Dolan","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2009.06.006","article-title":"Vaccinia virus vaccines: past, present and future","volume":"84","author":"Jacobs","year":"2009","journal-title":"Antivir. Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/infdis\/156.2.293","article-title":"Human monkeypox: clinical features of 282 patients","volume":"156","author":"Jezek","year":"1987","journal-title":"J. Infect. Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12985-024-02616-3","article-title":"Evolutionary variation of the monkeypox virus detected for the first time in Nantong, Jiangsu","volume":"21","author":"Ji","year":"2024","journal-title":"Jiangsu. Virol. J."},{"key":"B76","doi-asserted-by":"publisher","first-page":"106480","DOI":"10.1016\/j.pep.2024.106480","article-title":"Expression, purification, and crystal structure of mpox virus A41 protein","volume":"219","author":"Jiang","year":"2024","journal-title":"Protein Expr. Purif."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1128\/JVI.01931-10","article-title":"Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route","volume":"85","author":"Johnson","year":"2011","journal-title":"J. Virol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.cyto.2008.05.016","article-title":"Monkeypox virus viral chemokine inhibitor (MPV vCCI), a potent inhibitor of rhesus macrophage inflammatory protein-1","volume":"43","author":"Jones","year":"2008","journal-title":"Cytokine"},{"key":"B79","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1126\/science.adf3764","article-title":"Making trouble","volume":"378","author":"Kaiser","year":"2022","journal-title":"Science"},{"key":"B80","doi-asserted-by":"publisher","first-page":"102928","DOI":"10.1016\/j.jaut.2022.102928","article-title":"Mutations in the monkeypox virus replication complex: potential contributing factors to the 2022 outbreak","volume":"133","author":"Kannan","year":"2022","journal-title":"J. Autoimmun."},{"key":"B81","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.cmi.2016.07.004","article-title":"Emerging diseases-the monkeypox epidemic in the democratic Republic of the Congo","volume":"22","author":"Kantele","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"B82","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jiph.2023.02.003","article-title":"Monkeypox (mpox) virus: classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis","volume":"16","author":"Karagoz","year":"2023","journal-title":"J. Infect. Public Health"},{"key":"B83","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1111\/tmi.13821","article-title":"The re-emerging monkeypox disease","volume":"27","author":"Kipkorir","year":"2022","journal-title":"Trop. Med. Int. Health"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1371\/journal.pmed.0030272","article-title":"Frequency of adverse events after vaccination with different vaccinia strains","volume":"3","author":"Kretzschmar","year":"2006","journal-title":"PLoS Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3201\/eid2002.130118","article-title":"Genomic variability of monkeypox virus among humans, democratic Republic of the Congo","volume":"20","author":"Kugelman","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1126\/science.ade8470","article-title":"Moving target","volume":"377","author":"Kupferschmidt","year":"2022","journal-title":"Science"},{"key":"B87","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/toxs.1998.2481","article-title":"Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys","volume":"44","author":"Lacy","year":"1998","journal-title":"Toxicol. Sci."},{"key":"B88","first-page":"593","article-title":"A human infection caused by monkeypox virus in basankusu territory, democratic Republic of the Congo","volume":"46","author":"Ladnyj","year":"1972","journal-title":"Bull. World Health Organ"},{"key":"B89","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/infdis\/jiad034","article-title":"Clinical features, antiviral treatment, and patient outcomes: a systematic review and comparative analysis of the previous and the 2022 mpox outbreaks","volume":"228","author":"Li","year":"2023","journal-title":"J. Infect. Dis."},{"key":"B90","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/med.22085","article-title":"An overview of the progress made in research into the Mpox virus","volume":"45","author":"Li","year":"2025","journal-title":"Med. Res. Rev."},{"key":"B91","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40249-022-01007-6","article-title":"Monkeypox claims new victims: the outbreak in men who have sex with men","volume":"11","author":"Liu","year":"2022","journal-title":"Infect. Dis. Poverty"},{"key":"B92","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/pathogens12010146","article-title":"Clinical characteristics of human mpox (Monkeypox) in 2022: a systematic review and meta-analysis","volume":"12","author":"Liu","year":"2023","journal-title":"Pathogens"},{"key":"B93","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41392-023-01675-2","article-title":"Mpox (formerly monkeypox): pathogenesis, prevention, and treatment","volume":"8","author":"Lu","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"B94","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","article-title":"Monkeypox: disease epidemiology, host immunity and clinical interventions","volume":"22","author":"Lum","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"13358","DOI":"10.1021\/acs.jmedchem.5c00019","article-title":"Discovery of small-molecule orthopoxvirus resolvase inhibitors with antiviral activity","volume":"68","author":"Mahoney","year":"2025","journal-title":"J. Med. Chem."},{"key":"B96","doi-asserted-by":"publisher","first-page":"126409","DOI":"10.1016\/j.vaccine.2024.126409","article-title":"MVA-BN vaccine effectiveness: a systematic review of real-world evidence in outbreak settings","volume":"42","author":"Mason","year":"2024","journal-title":"Vaccine"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1099\/jgv.0.000422","article-title":"New effective chemically synthesized anti-smallpox compound NIOCH-14","volume":"97","author":"Mazurkov","year":"2016","journal-title":"J. Gen. Virol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/cid\/cit703","article-title":"Human monkeypox","volume":"58","author":"McCollum","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1086\/421266","article-title":"Modified vaccinia Ankara: potential as an alternative smallpox vaccine","volume":"38","author":"McCurdy","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"B100","first-page":"37","article-title":"Section IV\u2014Laboratory biosafety level criteria","volume-title":"Biosafety in microbiological and biomedical laboratories, birkh\u00e4user advances in infectious diseases","author":"Meechan","year":""},{"key":"B101","first-page":"529","article-title":"Appendix N\u2014clinical laboratories","volume-title":"Biosafety in microbiological and biomedical laboratories, birkh\u00e4user advances in infectious diseases","author":"Meechan","year":""},{"key":"B102","doi-asserted-by":"publisher","first-page":"47302","DOI":"10.18632\/oncotarget.10100","article-title":"Cidofovir is active against human papillomavirus positive and negative head and neck and cervical tumor cells by causing DNA damage as one of its working mechanisms","volume":"7","author":"Mertens","year":"2016","journal-title":"Oncotarget"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence","volume":"72","author":"Meyer","year":"1991","journal-title":"J. General Virology"},{"key":"B104","doi-asserted-by":"publisher","first-page":"11779322221141164","DOI":"10.1177\/11779322221141164","article-title":"Drug and anti-viral peptide design to inhibit the monkeypox virus by restricting A36R protein","volume":"16","author":"Miah","year":"2022","journal-title":"Bioinform Biol. Insights"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e77892","DOI":"10.7759\/cureus.77892","article-title":"Epidemiology, pathogenesis, and treatment options of monkeypox: a narrative review","volume":"17","author":"Mishra","year":"2025","journal-title":"Cureus"},{"key":"B106","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(23)00273-8","article-title":"Mpox in people with advanced HIV infection: a global case series","volume":"401","author":"Mitj\u00e0","year":"","journal-title":"Lancet"},{"key":"B107","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0140-6736(22)02075-X","article-title":"Monkeypox","volume":"401","author":"Mitj\u00e0","year":"","journal-title":"Lancet"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2200448","DOI":"10.2807\/1560-7917.ES.2022.27.24.2200448","article-title":"Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022","volume":"27","author":"Miura","year":"2022","journal-title":"Euro Surveill."},{"key":"B109","unstructured":"Monkeypox: House investigators find NIH hiding risky viral gain-of-function research\n          \n          \n            \n              Moffit\n              R.\n            \n            \n              Howell\n              M.\n            \n          \n          \n          2024"},{"key":"B110","doi-asserted-by":"publisher","first-page":"102636","DOI":"10.1016\/j.tmaid.2023.102636","article-title":"Addressing the resurgence of global monkeypox (Mpox) through advanced drug delivery platforms","volume":"56","author":"Mohanto","year":"2023","journal-title":"Travel Med. Infect. Dis."},{"key":"B111","doi-asserted-by":"publisher","first-page":"vead031","DOI":"10.1093\/ve\/vead031","article-title":"Selective events at individual sites underlie the evolution of monkeypox virus clades","volume":"9","author":"Molteni","year":"2023","journal-title":"Virus Evol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1038\/s41467-024-46949-7","article-title":"Monkeypox virus genomic accordion strategies","volume":"15","author":"Monz\u00f3n","year":"2024","journal-title":"Nat. Commun."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3201\/eid1107.050277","article-title":"Adventitious agents and smallpox vaccine in strategic national stockpile","volume":"11","author":"Murphy","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"B114","doi-asserted-by":"publisher","first-page":"ofx168","DOI":"10.1093\/ofid\/ofx168","article-title":"A nosocomial outbreak of human monkeypox in the Central African Republic","volume":"4","author":"Nakoune","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"B115","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/dddt.s3687","article-title":"ACAM2000: the new smallpox vaccine for United States strategic national stockpile","volume":"4","author":"Nalca","year":"2010","journal-title":"Drug Des. Devel Ther."},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1101\/2023.10.04.23296566","article-title":"Effectiveness of one dose of MVA-BN vaccine against mpox infection in males in Ontario, Canada: a target trial emulation","author":"Navarro","year":"2023"},{"key":"B117","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S0140-6736(22)01497-0","article-title":"Sexual behaviours and clinical course of human monkeypox in Spain","volume":"400","author":"Ogoina","year":"2022","journal-title":"Lancet"},{"key":"B118","doi-asserted-by":"publisher","first-page":"ciaf074","DOI":"10.1093\/cid\/ciaf074","article-title":"LC16m8 for pre-exposure prophylaxis against mpox in a high-risk population: an open-label randomized trial","author":"Okumura","year":"2025","journal-title":"Clin. Infect. Dis. ciaf074"},{"key":"B119","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41591-024-03370-3","article-title":"Global genomic surveillance of monkeypox virus","volume":"31","author":"Otieno","year":"2025","journal-title":"Nat. Med."},{"key":"B120","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.adg8116","article-title":"APOBEC3 deaminase editing in mpox virus as evidence for sustained human transmission since at least 2016","volume":"382","author":"O\u2019Toole","year":"2023","journal-title":"Science"},{"key":"B121","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/B978-012373944-5.00178-4","article-title":"Antiviral agents","volume-title":"Encyclopedia of microbiology","author":"Paintsil","year":"2009"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1056\/NEJMoa2412439","article-title":"Tecovirimat for clade I MPXV infection in the democratic republic of Congo","volume":"392","author":"Ali","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"e28534","DOI":"10.1002\/jmv.28534","article-title":"Transmission of monkeypox\/mpox virus: a narrative review of environmental, viral, host, and population factors in relation to the 2022 international outbreak","volume":"95","author":"Pan","year":"2023","journal-title":"J. Med. Virol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"5364","DOI":"10.1073\/pnas.80.17.5364","article-title":"Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin","volume":"80","author":"Panicali","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.jaci.2006.09.037","article-title":"Smallpox vaccines: past, present, and future","volume":"118","author":"Parrino","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.15585\/mmwr.mm7149a5","article-title":"Reduced risk for mpox after receipt of 1 or 2 doses of JYNNEOS vaccine compared with risk among unvaccinated persons - 43 U.S. jurisdictions, July 31-October 1, 2022","volume":"71","author":"Payne","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.idc.2019.03.001","article-title":"Human monkeypox: Epidemiologic and clinical characteristics, diagnosis, and prevention","volume":"33","author":"Petersen","year":"2019","journal-title":"Infect. Dis. Clin. North Am."},{"key":"B128","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jiph.2023.11.015","article-title":"Pharyngo-tonsillar involvement of Mpox in a cohort of men who have sex with men (MSM): a serious risk of missing diagnosis","volume":"17","author":"Pinnetti","year":"2024","journal-title":"J. Infect. Public Health"},{"key":"B129","doi-asserted-by":"publisher","first-page":"e0010384","DOI":"10.1371\/journal.pntd.0010384","article-title":"Clinical characterization and placental pathology of mpox infection in hospitalized patients in the Democratic Republic of the Congo","volume":"17","author":"Pittman","year":"2023","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B130","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/j.vaccine.2005.01.012","article-title":"The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program","volume":"23","author":"Poland","year":"2005","journal-title":"Vaccine"},{"key":"B131","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1016\/S1473-3099(25)00014-3","article-title":"Antiviral activity of tecovirimat against monkeypox virus clades 1a, 1b, 2a, and 2b","volume":"25","author":"Postal","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"B132","doi-asserted-by":"publisher","first-page":"105995","DOI":"10.1016\/j.antiviral.2024.105995","article-title":"Treatment efficacy of cidofovir and brincidofovir against clade II monkeypox virus isolates","volume":"231","author":"Pr\u00e9vost","year":"2024","journal-title":"Antivir. Res."},{"key":"B133","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/fmicb.2020.00603","article-title":"Discovery of Retro-1 analogs exhibiting enhanced anti-vaccinia virus activity","volume":"11","author":"Priyamvada","year":"2020","journal-title":"Front. Microbiol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.3390\/biomedicines11071832","article-title":"An updated review on monkeypox viral disease: emphasis on genomic diversity","volume":"11","author":"Rabaan","year":"2023","journal-title":"Biomedicines"},{"key":"B135","doi-asserted-by":"publisher","first-page":"ofad528","DOI":"10.1093\/ofid\/ofad528","article-title":"Effectiveness of the modified vaccinia Ankara vaccine against mpox in men who have sex with men: a retrospective cohort analysis, Seattle, Washington","volume":"10","author":"Ramchandani","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"B136","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nm1265","article-title":"Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases","volume":"11","author":"Reeves","year":"2005","journal-title":"Nat. Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1128\/JVI.01814-10","article-title":"Variola and monkeypox viruses utilize conserved mechanisms of virion motility and release that depend on abl and SRC family tyrosine kinases","volume":"85","author":"Reeves","year":"2011","journal-title":"J. Virol."},{"key":"B138","first-page":"397","article-title":"Environmental resistance, disinfection, and sterilization of poxviruses","volume-title":"Poxviruses, birkh\u00e4user advances in infectious diseases","author":"Rheinbaben","year":"2007"},{"key":"B139","doi-asserted-by":"publisher","first-page":"16262","DOI":"10.1073\/pnas.1005769107","article-title":"Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the democratic Republic of Congo","volume":"107","author":"Rimoin","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B140","doi-asserted-by":"publisher","first-page":"559","DOI":"10.15585\/mmwr.mm7220a4","article-title":"Effectiveness of JYNNEOS vaccine against diagnosed mpox infection - new York, 2022","volume":"72","author":"Rosenberg","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B141","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3201\/eid0706.010602","article-title":"Developing new smallpox vaccines","volume":"7","author":"Rosenthal","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"B142","doi-asserted-by":"publisher","first-page":"104749","DOI":"10.1016\/j.idnow.2023.104749","article-title":"Absence of association between persistent skin lesion and virological replication in severe disseminated monkeypox infection in solid organ transplant recipient","volume":"53","author":"Rousseau","year":"2023","journal-title":"Infect. Dis. Now."},{"key":"B143","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.2174\/092986706778773059","article-title":"Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research","volume":"13","author":"Russmann","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"B144","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/14787210.2020.1819791","article-title":"An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications","volume":"19","author":"Russo","year":"2021","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1414224","DOI":"10.3389\/fcimb.2024.1414224","article-title":"Exploring monkeypox virus proteins and rapid detection techniques","volume":"14","author":"Sagdat","year":"2024","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"992","DOI":"10.15585\/mmwr.mm7236a4","article-title":"Reduced odds of Mpox-Associated hospitalization among persons who received JYNNEOS vaccine - california, May 2022-May 2023","volume":"72","author":"Schildhauer","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B147","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00415-022-11339-w","article-title":"Monkeypox virus from neurological complications to neuroinvasive properties: current status and future perspectives","volume":"270","author":"Sepehrinezhad","year":"2023","journal-title":"J. Neurol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/0014-5793(93)80041-r","article-title":"Genes of variola and vaccinia viruses necessary to overcome the host protective mechanisms","volume":"319","author":"Shchelkunov","year":"1993","journal-title":"FEBS Lett."},{"key":"B149","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/cid\/ciac622","article-title":"Antivirals with activity against mpox: a clinically oriented review","volume":"76","author":"Siegrist","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"B150","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1743-422X-4-8","article-title":"From actually toxic to highly specific--novel drugs against poxviruses","volume":"4","author":"Sliva","year":"2007","journal-title":"Virol. J."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1128\/AAC.46.5.1329-1335.2002","article-title":"Characterization of wild-type and Cidofovir-Resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses","volume":"46","author":"Smee","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B152","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.3201\/eid2912.231146","article-title":"Tecovirimat resistance in mpox patients, United States, 2022-2023","volume":"29","author":"Smith","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"B153","doi-asserted-by":"publisher","first-page":"105662","DOI":"10.1016\/j.jcv.2024.105662","article-title":"Human monkeypox virus: epidemiologic review and research progress in diagnosis and treatment","volume":"171","author":"Sun","year":"2024","journal-title":"J. Clin. Virol."},{"key":"B154","first-page":"222","article-title":"The immunogenic properties of a recombinant vaccinia virus with an incorporated DNA copy of the 26S RNA of the Venezuelan equine encephalomyelitis virus","volume":"38","author":"Sviatchenko","year":"1993","journal-title":"Vopr. Virusol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1203410","DOI":"10.3389\/fimmu.2023.1203410","article-title":"Recombinant proteins A29L, M1R, A35R, and B6R vaccination protects mice from mpox virus challenge","volume":"14","author":"Tang","year":"2023","journal-title":"Front. Immunol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1006\/exer.1996.0273","article-title":"An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects","volume":"64","author":"Taskintuna","year":"1997","journal-title":"Exp. Eye Res."},{"key":"B157","unstructured":"Mpox virus: clade I and clade II"},{"key":"B158","unstructured":"Mpox virus: clade I and clade II"},{"key":"B159","unstructured":"Interim staff report on investigation into risky MPXV experiment at the national institute of allergy and infectious diseases\n          \n          \n          2024"},{"key":"B160","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries - april-june 2022","volume":"387","author":"Thornhill","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1001\/jama.2024.21091","article-title":"Mpox clinical presentation, diagnostic approaches, and treatment strategies: a review","volume":"332","author":"Titanji","year":"2024","journal-title":"JAMA"},{"key":"B162","unstructured":"Vaccine doses allocated to nine African countries hardest hit by mpox surge\n          \n          \n          2024"},{"key":"B163","unstructured":"Mpox. FDA\u2019s role in mpox preparedness and response, and information about mpox (formerly referred to as monkeypox)\n          \n          \n          2024"},{"key":"B164","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.cmi.2023.09.014","article-title":"Beware of drug resistance: let\u2019s not lose tecovirimat against mpox","volume":"30","author":"Van Dijck","year":"2024","journal-title":"Clin. Microbiol. Infect."},{"key":"B165","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s42003-024-06239-w","article-title":"The implications of APOBEC3-mediated C-to-U RNA editing for human disease","volume":"7","author":"Van Norden","year":"2024","journal-title":"Commun. Biol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1800509","DOI":"10.2807\/1560-7917.ES.2018.23.38.1800509","article-title":"Two cases of monkeypox imported to the United Kingdom, September 2018","volume":"23","author":"Vaughan","year":"2018","journal-title":"Euro Surveill."},{"key":"B167","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3201\/eid2604.191164","article-title":"Human-to-Human transmission of monkeypox virus, United Kingdom, October 2018","volume":"26","author":"Vaughan","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"B168","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1016\/j.vaccine.2020.08.050","article-title":"The brighton collaboration standardized template for collection of key information for risk\/benefit assessment of a modified vaccinia Ankara (MVA) vaccine platform","volume":"39","author":"Volkmann","year":"2021","journal-title":"Vaccine"},{"key":"B169","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1016\/j.molcel.2023.10.038","article-title":"Structural insights into the assembly and mechanism of mpox virus DNA polymerase complex F8-A22-E4-H5","volume":"83","author":"Wang","year":"2023","journal-title":"Mol. Cell"},{"key":"B170","doi-asserted-by":"publisher","first-page":"eade7646","DOI":"10.1126\/scitranslmed.ade7646","article-title":"In vitro and in vivo efficacy of tecovirimat against a recently emerged 2022 monkeypox virus isolate","volume":"14","author":"Warner","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"B171","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.vaccine.2006.09.046","article-title":"An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies","volume":"25","author":"Wiser","year":"2007","journal-title":"Vaccine"},{"key":"B172","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41591-023-02229-3","article-title":"Real-world effectiveness of a single dose of mpox vaccine in males","volume":"29","author":"Wolff Sagy","year":"2023","journal-title":"Nat. Med."},{"key":"B177","unstructured":"Mpox"},{"key":"B174","unstructured":"WHO director-general declares mpox outbreak a public health emergency of international concern"},{"key":"B175","unstructured":"Public advice on mpox vaccination"},{"key":"B176","unstructured":"Mpox: multi-country external situation report no.57"},{"key":"B178","doi-asserted-by":"publisher","first-page":"e2411686122","DOI":"10.1073\/pnas.2411686122","article-title":"Structural basis of DNA replication fidelity of the Mpox virus","volume":"122","author":"Xie","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B179","doi-asserted-by":"publisher","first-page":"100185","DOI":"10.1016\/j.cellin.2024.100185","article-title":"The monkeypox virus-host interplays","volume":"3","author":"Yi","year":"2024","journal-title":"Cell Insight"},{"key":"B180","doi-asserted-by":"publisher","first-page":"e13776","DOI":"10.1111\/tid.13776","article-title":"Cidofovir, a choice for salvage treatment of cytomegalovirus infection in patients with haploidentical hematopoietic stem cell transplantation","volume":"24","author":"Yin","year":"2022","journal-title":"Transpl. Infect. Dis."},{"key":"B181","doi-asserted-by":"publisher","first-page":"e0057624","DOI":"10.1128\/msphere.00576-24","article-title":"Exploring the genomic basis of Mpox virus-host transmission and pathogenesis","volume":"9","author":"Young","year":"2024","journal-title":"mSphere"},{"key":"B182","doi-asserted-by":"publisher","first-page":"8241","DOI":"10.1038\/s41467-023-44092-3","article-title":"Phylogeny and molecular evolution of the first local monkeypox virus cluster in Guangdong Province, China","volume":"14","author":"Yu","year":"2023","journal-title":"Nat. Commun."},{"key":"B183","doi-asserted-by":"publisher","first-page":"110763","DOI":"10.1016\/j.ygeno.2023.110763","article-title":"Genome analysis of the mpox (formerly monkeypox) virus and characterization of core\/variable regions","volume":"116","author":"Yu","year":"2024","journal-title":"Genomics"},{"key":"B184","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-022-02090-w","article-title":"Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals","volume":"29","author":"Zaeck","year":"2023","journal-title":"Nat. Med."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jobb.2022.12.004","article-title":"Potential threat of human pathogenic orthopoxviruses to public health and control strategies","volume":"5","author":"Zhang","year":"2023","journal-title":"J. Biosaf. Biosecur"},{"key":"B186","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41421-024-00680-1","article-title":"Structural and functional insights into the helicase protein E5 of Mpox virus","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Discov."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1665830\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T05:42:35Z","timestamp":1758692555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1665830\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":185,"alternative-id":["10.3389\/fphar.2025.1665830"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1665830","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"article-number":"1665830"}}